Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
August 25, 2021
Role of weight bias and patient-physician communication in the underutilization of bariatric surgery
David B Sarwer, Hamlet Gasoyan, Sarah Bauerle Bass, et al.
Vaccine
|
November 6, 2018
Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova
Silas P Trumbo, Dana Silver, Oxana Domenti, et al.
Diabetes, Obesity & Metabolism
|
June 20, 2025
Socio-demographic and clinical factors associated with the receipt of anti-obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants
Olajide A Adekunle, Phuc Le, Dev Yash Gupta, et al.
Blood Cancer Journal
|
August 23, 2024
Disparities in time to treatment with oral antimyeloma medications
Hamlet Gasoyan, Faiz Anwer, Jeffrey D Kovach, et al.
JCO Oncology Practice
|
February 14, 2024
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities
Hamlet Gasoyan, Faiz Anwer, Nicholas J Casacchia, et al.
Obesity (Silver Spring, Md.)
|
February 25, 2026
Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
Olajide A Adekunle, Phuc Le, Christopher Boyer, et al.
The American Journal of Psychiatry
|
November 1, 2024
Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants
Phuc Le, Jacob James Rich, Eden Y Bernstein, et al.
Obesity (Silver Spring, Md.)
|
June 10, 2025
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status
Hamlet Gasoyan, W Scott Butsch, Rebecca Schulte, et al.
Obesity (Silver Spring, Md.)
|
October 3, 2025
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
Hamlet Gasoyan, W Scott Butsch, Nicholas J Casacchia, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
December 26, 2021
10-year weight loss outcomes after Roux-en-Y gastric bypass and attendance at follow-up visits: a single-center study
Su-Hsin Chang, Hamlet Gasoyan, Mei Wang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
August 25, 2021
Role of weight bias and patient-physician communication in the underutilization of bariatric surgery
David B Sarwer, Hamlet Gasoyan, Sarah Bauerle Bass, et al.
Vaccine
|
November 6, 2018
Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova
Silas P Trumbo, Dana Silver, Oxana Domenti, et al.
Diabetes, Obesity & Metabolism
|
June 20, 2025
Socio-demographic and clinical factors associated with the receipt of anti-obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants
Olajide A Adekunle, Phuc Le, Dev Yash Gupta, et al.
Blood Cancer Journal
|
August 23, 2024
Disparities in time to treatment with oral antimyeloma medications
Hamlet Gasoyan, Faiz Anwer, Jeffrey D Kovach, et al.
JCO Oncology Practice
|
February 14, 2024
Role of Patient Characteristics and Insurance Type in Newly Diagnosed Multiple Myeloma Care Disparities
Hamlet Gasoyan, Faiz Anwer, Nicholas J Casacchia, et al.
Obesity (Silver Spring, Md.)
|
February 25, 2026
Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
Olajide A Adekunle, Phuc Le, Christopher Boyer, et al.
The American Journal of Psychiatry
|
November 1, 2024
Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants
Phuc Le, Jacob James Rich, Eden Y Bernstein, et al.
Obesity (Silver Spring, Md.)
|
June 10, 2025
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status
Hamlet Gasoyan, W Scott Butsch, Rebecca Schulte, et al.
Obesity (Silver Spring, Md.)
|
October 3, 2025
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
Hamlet Gasoyan, W Scott Butsch, Nicholas J Casacchia, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
|
December 26, 2021
10-year weight loss outcomes after Roux-en-Y gastric bypass and attendance at follow-up visits: a single-center study
Su-Hsin Chang, Hamlet Gasoyan, Mei Wang, et al.
Page
of 4